Related Experiment Videos
Descending control of pain
1Anaesthetics Unit, London Hospital Medical College, London Hospital, Whitechapel.
British Journal of Anaesthesia
|August 1, 1995
Summary
The descending pain control system involves monoamines like serotonin and norepinephrine. Research continues to unravel the complex roles of these neurotransmitters and their receptors in pain modulation.
Area of Science:
- Neuroscience
- Pain Research
- Neuropharmacology
Background:
- Descending pain control is mediated by brainstem nuclei.
- Monoamines, including serotonin (5-HT) and norepinephrine (NA), play critical roles.
- The exact mechanisms and differential roles of these amines are still under investigation.
Purpose of the Study:
- To review the established and emerging roles of monoamines in descending pain control.
- To highlight the complexities and ongoing research questions in this field.
Main Methods:
- Review of existing literature on stimulation analgesia and descending pain control.
- Analysis of the roles of specific brainstem nuclei (periaqueductal grey, raphe nuclei, locus coeruleus).
Main Results:
- Monoamines (5-HT and NA) are key in descending pain control.
- Opiates and GABA are also involved, with receptor roles debated.
- Electrical stimulation studies are complicated by current spread.
Conclusions:
- Monoaminergic pathways are crucial for pain modulation.
- Further research is needed to clarify the precise roles of different neurotransmitters and receptors.
- Understanding these ancient systems remains vital for pain management.